Electronrx Limited
Research and experimental development on biotechnology · Cambridge
ActiveUnited KingdomIncorporated 2017Private Limited Company
Financial position
Accounts to 2026-03-31 · GBP · company scope
Net assets
£3,995,683
Cash
£4,034,874
Turnover
—
Profit / loss
−£315,579
Current assets
£4,237,414
Creditors < 1 year
—
Equity
£3,995,683
Average employees
18
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2026-03-31GBP · company | 2025-03-31GBP · company |
|---|---|---|
| Balance sheet | ||
| Net assets | £3,995,683 | £3,414,112 |
| Equity | £3,995,683 | £3,414,112 |
| Assets | ||
| Fixed assets | £14,193 | £21,145 |
| Property, plant & equipment | £14,133 | £21,085 |
| Current assets | £4,237,414 | £3,543,148 |
| Cash at bank | £4,034,874 | £3,508,758 |
| Debtors | £202,540 | £34,390 |
| Liabilities | ||
| Net current assets | £3,981,490 | £3,392,967 |
| Assets less current liabilities | £3,995,683 | £3,414,112 |
| Profit & loss | ||
| Profit / loss | −£315,579 | — |
| People | ||
| Average employees | 18 | 16 |
| Source evidence | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.